From: Enhanced detection of metastatic prostate cancer cells in human plasma with lipid bodies staining
Spot number | Protein name | LNCaP control | LNCaP + plasma | RWPE1 control | RWPE1 + plasma | Biological function |
---|---|---|---|---|---|---|
1 | UPF0556 protein C19orf10 | √ | √ | - | - | Unfolded Protein Response |
2 | Histone H2B type 1-M | √ | - | √ | √ | Nucleosome Assembly |
3 | Histone H2B type 1-M | √ | - | √ | √ | Nucleosome Assembly |
4 | Delta (3,5)-Delta (2,4)-dienoyl-CoA isomerase, mitochondrial | √ | √ | - | - | Fatty Acid Metabolim |
5 | Keratin, type II cytoskeletal 6A | √ | √ | √ | √ | Cytoskeletal Structure |
6 | Keratin, type II cytoskeletal 6B | √ | √ | √ | √ | Cytoskeletal Structure |
7 | Phosphoglycerate mutase 1 | - | √ | - | - | Glycolysis |
8 | Elongation factor 2 | - | √ | - | - | Protein Synthesis |
9 | Trifunctional enzyme subunit alpha, mitochondrial | - | - | √ | - | Fatty Acid β-oxidation |
10 | Procollagen galactosyltransferase 1 | - | - | √ | √ | ECM Organization |
11 | Keratin, type II cytoskeletal 7 | - | - | √ | √ | Cytoskeletal Structure |
12 | Keratin, type I cytoskeletal 14 | - | - | √ | √ | Cytoskeletal Structure |
13 | Keratin, type I cytoskeletal 17 | - | - | √ | √ | Cytoskeletal Structure |
14 | Vimentin | - | - | √ | √ | Cytoskeletal Structure |
15 | Vimentin | - | - | √ | - | Cytoskeletal Structure |